Reveleer Unveils Global Capability Center in India to Accelerate AI-Powered Value-Based Care Solutions

Delivering around the clock innovation to its customers, Reveleer enhances its scalability, operational efficiency, and service delivery

GLENDALE, Calif., March 11, 2025 /PRNewswire/ — Reveleer, the industry’s pioneering value-based care platform, today announced the opening of a global capability center (GCC) in the IT corridor OMR in Chennai, India. This expansion marks a key milestone in the company’s ongoing efforts to scale operations and meet the growing demand for its innovative AI-powered, intelligent automation solutions.

The expansion comes as Reveleer continues to experience significant growth. The team in India will enhance scalability, operational efficiency, and service delivery, while partnering with U.S.-based team members and customers. By opening the GCC in India, Reveleer strengthens its global workforce, supporting product, engineering, operations, medical coding, and quality assurance.

“This expansion is a direct response to increasing demand for our value-based care solutions and to provide the best possible outcomes to our customers,” said Jay Ackerman, CEO of Reveleer. “We’ve been fortunate to work alongside exceptional partners in India since 2016, and our expansion will allow us to engage a deep pool of talent, accelerate innovation, and expand our ability to help payers and providers improve efficiency, enhance patient care, and strengthen their financial performance.”

Reveleer has appointed industry veteran Shanmugam Nagappan as Managing Director for India, tasked with setting up and growing the GCC in Chennai. Before joining Reveleer, Shanmugam was COO at Replicon India, and Managing Director (India) at IMMO, where he established and expanded the technology and global operations hubs across multiple cities in India.

“I am thrilled to be joining Reveleer at such an exciting time for the company. Our India team will play a strategic role in advancing Reveleer’s business initiatives and innovation, operating as a seamless extension of our U.S. counterparts,” said Shanmugam Nagappan, Managing Director, GCC. “We are committed to supporting our customers and colleagues, while providing local teams with the resources needed to further our mission.”

Reveleer is committed to delivering cutting-edge value-based care solutions and improving healthcare. This expansion underscores the company’s continued leadership and growth within value-based care and the broader healthcare industry.

To learn more about Reveleer, visit reveleer.com.

About Reveleer
As the industry’s pioneering value-based care (VBC) enablement platform, Reveleer is purpose-built to solve the most pressing real-world challenges faced by provider and health-plan organizations today. By unifying retrieval, clinical intelligence, risk adjustment, quality improvement, and member management solutions into one intelligent, AI powered system, Reveleer streamlines fragmented workflows to supercharge productivity, enhance care quality, and optimize performance on high-priority value-based initiatives. To learn more about Reveleer’s value-based care platform, visit us at Reveleer.com.

View original content to download multimedia:https://www.prnewswire.com/news-releases/reveleer-unveils-global-capability-center-in-india-to-accelerate-ai-powered-value-based-care-solutions-302397773.html

SOURCE Reveleer

Staff

Recent Posts

UOG (United One Group) Wins Three Prestigious Industry Awards at CES 2026

CES Official Spokesperson Highlights UOG Featured ProductsIntroducing the World's First Black Diamond Carbon & Nano…

2 hours ago

Best Ipamorelin vs Sermorelin: Growth Hormone Peptide Comparison 2026 — ReadyRx Prescription Telehealth Analysis

Independent research summary reviews mechanisms, regulatory considerations, and telehealth access pathways as consumers compare growth…

5 hours ago

GLP-1 Booster From Health Journey: 2026 Ingredient Analysis And Probiotic Metabolic Support Explained

Examining Akkermansia Muciniphila, Clostridium Butyricum, And The Gut Microbiome Research Behind This Probiotic GLP-1 Supplement…

5 hours ago

MEDVi GLP-1 Investigation: What Consumer Data Shows About Compounded Telehealth Weight Loss Programs

Independent Analysis Examines MEDVi's Semaglutide Medication Model, FDA Compounding Framework, and Prescription Accessibility Trends Heading…

5 hours ago

Best Peptides for Anti-Aging: NAD+ Delivery Methods Compared as Telehealth Platforms Expand Access (2026 Analysis)

Published NAD+ research examines cellular aging pathways and mitochondrial function as prescription peptide injection access…

5 hours ago

Foghorn Therapeutics Highlights January Equity Financing, Program Progress and Strategic Objectives for 2026

Recently raised $50 million with BVF Partners, Deerfield Management, founding investor Flagship Pioneering and a…

5 hours ago